Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
Overall activity in deals jumped 11% in North America.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
It’s too early to tell how the new administration will affect the device industry, but user fees, the ACA and the FDA regulatory process are top of mind.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.